Navigation Links
Aratana Therapeutics Adds To Drug Development Team
Date:3/26/2013

KANSAS CITY, Kan. and BOSTON, March 26, 2013 /PRNewswire/ -- Aratana Therapeutics, Inc., a biopharmaceutical company focused on licensing, developing and commercializing innovative prescription medications for cats and dogs (companion animals), today announced it has expanded its relationship with Marie-Paul Lachaud , DVM, as a consultant to the company who will lead drug evaluation and development in Europe.  Dr. Lachaud is a seasoned animal health executive whose work has led to significant companion animal health product approvals in Europe.  Additionally, Aratana expanded its U.S. drug development team to include Laura Simon Treml , VMD, Ph.D., as Director of Drug Development and Glenda L. Armintrout as Senior Research Associate, each of whom bring significant expertise in overseeing clinical programs in companion animals. 

Ernst Heinen , DVM, Ph.D., Head of Aratana's Drug Evaluation and Development, stated, "We're delighted that Marie-Paul has expanded her role with us.  Her engagement represents Aratana's first presence outside of the United States, and we could not ask for a better suited professional to lead our development efforts for the European market.  We are also fortunate to add Laura and Glenda to our team, as we focus on execution of our clinical development programs for our current drug candidates.  Given the strength of their backgrounds in companion animal drug development, we believe we will be well served by their expertise."

Marie-Paul Lachaud , DVM
Dr. Lachaud, whose prior experience focused on international development for animal drugs, was the European animal health director at ICON Clinical Research in <
'/>"/>

SOURCE Aratana Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Aratana Therapeutics Completes $15 Million Series B Financing
2. Aratana Therapeutics Appoints Craig Tooman to Board of Directors
3. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives
4. Aratana Closes $10 Million Non-Dilutive Financing with Square 1 Bank
5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
7. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
8. Fate Therapeutics Strengthens Its iPSC Platform
9. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
10. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
11. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 The ... such as its definition, classification, application and ... specification, manufacturing process, and product cost structure. ... applications. The analysis also covers upstream raw ... industry development trend and proposals. In the ...
(Date:12/24/2014)... Diego, CA (PRWEB) December 23, 2014 ... where their Twitter followers can submit their #HolidayInTheLab ... themselves and their lab mates. , For those struggling ... lab mates, the Pipette.com Holiday in the Lab Contest ... Pipette.com Twitter followers to send pictures of ...
(Date:12/24/2014)... -- PharmaBoardroom,s new report, , Healthcare ... for free download , digs deep into this vibrant ... the sector today. One area where ... developing a homegrown pharmaceutical manufacturing base, even if the government,s ... way off. A cursory comparison with neighboring Morocco ...
(Date:12/24/2014)... YORK , Dec. 23, 2014  NeuroLifeSciences announced ... mazindol in children with attention deficit/hyperactivity disorder published in ... . The paper, titled "Pilot Phase ... disorder" ( Konofal et al, Drug Des ... ) shows that mazindol might be an effective, ...
Breaking Biology Technology:Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3
... May 14, 2012   USHIFU, LLC (US HIFU), a ... ultrasound (HIFU) technologies, announced today that Mark Carol, ... chief development officer. With more than 25 years ... Dr. Carol will focus on continued development of ...
...  /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX ) ("3SBio" ... on researching, developing, manufacturing and marketing biopharmaceutical products, today ... ended March 31, 2012. First ... net revenues increased by 24.5% over the first quarter ...
... at Nanyang Technological University (NTU), it comes in the form of ... kills them without the need for antibiotics. The killer coating, ... and fungi that it comes in contact with, is now being ... specialising in animal care products. The next step is ...
Cached Biology Technology:US HIFU Adds Mark Carol, MD, As Chief Development Officer 2US HIFU Adds Mark Carol, MD, As Chief Development Officer 3US HIFU Adds Mark Carol, MD, As Chief Development Officer 43SBio Inc. Announces Unaudited First Quarter 2012 Results 23SBio Inc. Announces Unaudited First Quarter 2012 Results 33SBio Inc. Announces Unaudited First Quarter 2012 Results 43SBio Inc. Announces Unaudited First Quarter 2012 Results 53SBio Inc. Announces Unaudited First Quarter 2012 Results 63SBio Inc. Announces Unaudited First Quarter 2012 Results 73SBio Inc. Announces Unaudited First Quarter 2012 Results 83SBio Inc. Announces Unaudited First Quarter 2012 Results 93SBio Inc. Announces Unaudited First Quarter 2012 Results 103SBio Inc. Announces Unaudited First Quarter 2012 Results 11NTU scientists invent superbug killers 2NTU scientists invent superbug killers 3
(Date:12/17/2014)... 16, 2014  Automation is fundamentally transforming the ... than at international borders. Over the past decade, ... allowed veteran travelers to self process through border ... Kiosks at an increasing number of airports, seaports, ... According to Maxine Most , Principal ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced ... the APAC Region 2015-2019"  report to their offering. ... this market is advances in technology. With continuous ... biometric solutions to the latest standard that meets ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... world of the developing brain, neural stem cells give rise ... neurons then migrate along the stem cell fibers up to ... have discovered a key mechanism of this migration one ... processes and diseases, including cancer. The finding, the ...
... increases in consumption of sugar-sweetened beverages over the ... Type 2 diabetes mellitus, led nutritional epidemiologists at ... on Aging (USDA HNRCA) at Tufts University and ... consumption and insulin resistance, a precursor to Type ...
... years ago, "ultraconserved elements" were discovered in the genomes of ... pairs in length or longer -- some are over 700 ... the three species. They have been perfectly conserved since the ... some 85 million years ago. These and other ...
Cached Biology News:Neural stem cell study reveals mechanism that may play role in cancer 2Neural stem cell study reveals mechanism that may play role in cancer 3Neural stem cell study reveals mechanism that may play role in cancer 4Sugary drinks, not fruit juice, may be linked to insulin 2Sugary drinks, not fruit juice, may be linked to insulin 3Ultraconserved elements in the genome: Are they indispensable? 2Ultraconserved elements in the genome: Are they indispensable? 3Ultraconserved elements in the genome: Are they indispensable? 4
Edited by I.H. Pawlowitzki, J.H. Edwards and E.A. Thompson (1997) • This volume covers: Linkage in dominant recessive and oligogenic disease, Model free (non-parametric) methods, Tools for gene ...
... Cloning is the most ... cloning PCR products. TOPO ... Blunt TOPO vectors are ... with topoisomerase I. This ...
... TOPO Cloning is the ... for cloning PCR products. ... Zero Blunt TOPO vectors ... activated with topoisomerase I. ...
ready-to-use solution...
Biology Products: